Delivery Order SPE2DR25D1021-SPE2DR26FNL6C
- Not listed
- The Defense Logistics Agency awarded a $31,987.71 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Tagrisso 80 mg tablets under a firm fixed price contract. This delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This competitive award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance of this contract will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award, with no set-aside designation, reflects firm fixed-price pricing terms and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count supply) under a firm fixed-price contract. The award was issued on September 15, 2025, with an ultimate completion date of October 6, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement to support federal medical supply needs....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,662.57 on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The order, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this delivery order as a child contract under a...
- The Defense Logistics Agency awarded a delivery order valued at $53,312.85 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 9, 2025, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $63,889.44 to AmerisourceBergen Drug Corp for the supply of Tagrisso 40 mg tablets (30-count) on October 27, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). The contract is non-set-aside and competitively awarded, with an ultimate completion date of October 16, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $11,236.71. This firm fixed-price delivery order represents a competitive, non-set-aside award and is scheduled for completion by November 24, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL6CDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. This comprehensive contract vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The Tagrisso tablet order fulfills critical pharmaceutical needs within the federal medical supply chain and demonstrates AmerisourceBergen's continued role as a major vendor for defense healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 10/29/25 |